Cellular iron concentrations directly affect the expression levels of norepinephrine transporter in PC12 cells and rat brain tissue

Brain Research

Volumn 1092, Issue 1, 2006, Pages 47-58

  Beard, John L ^a   Wiesinger, Jason A ^a   Jones, Byron C ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Desferrioxamine; Iron chelation; Iron deficiency; Norepinephrine; Norepinephrine transporter; PC12 cell; Rat

Indexed keywords

CYCLOHEXIMIDE; DEFEROXAMINE MESYLATE; IRON; IRON CHELATING AGENT; MESSENGER RNA; NORADRENALIN TRANSPORTER; TRITIUM;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL CULTURE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; IRON CHELATION; IRON DEFICIENCY; LOCUS CERULEUS; NONHUMAN; NORADRENALIN UPTAKE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THALAMUS;

ANIMALS; BRAIN; DEFEROXAMINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD, FORMULATED; GENE EXPRESSION REGULATION; IRON; IRON CHELATING AGENTS; IRON METABOLISM DISORDERS; LOCUS COERULEUS; MALE; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PC12 CELLS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THALAMUS;

EID: 33746884257     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.03.071     Document Type: Article

References (52)

1. Algarin C., Peirano P., Garrido M., Pizarro F., and Lozoff B. Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr. Res. 53 (2003) 217-223
2. Angulo-Kinzler R.M., Peirano P., Lin E., Algarin C., Garrido M., and Lozoff B. Twenty-four-hour motor activity in human infants with and without iron deficiency anemia. Early Hum. Dev. 70 (2002) 85-101
3. Beard J. Iron deficiency alters brain development and functioning. J. Nutr. 133 (2003) 1468S-1472S
4. Beard J.L., and Connor J.R. Iron status and neural functioning. Annu. Rev. Nutr. 23 (2003) 41-58
5. Beard J.L., Chen Q., Connor J., and Jones B.C. Altered monamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol. Biochem. Behav. 48 (1994) 621-624
6. Beard J.L., Erikson K.M., and Jones B.C. Neurobehavioral analysis of developmental iron deficiency in rats. Behav. Brain Res. 134 (2002) 517-524
7. Blakely R.D., and Sung U. SNARE-ing neurotransmitter transporters. Nat. Neurosci. 3 (2000) 969-971
8. Burchett S.A., and Bannon M.J. Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration. Brain Res. Mol. Brain Res. 49 (1997) 95-102
9. Burhans M.S., Dailey C., Beard Z., Wiesinger J., Murray-Kolb L., Jones B.C., and Beard J.L. Iron deficiency: differential effects on monoamine transporters. Nutr. Neurosci. 8 (2005) 31-38
10. Clardy, S.L.W.X., Zhal, W., Liu, W., Chase, G.A., Beard, J.L., Felt, B.T., Connor, J.R., in press. Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain.
11. Dayani P.N., Bishop M.C., Black K., and Zeltzer P.M. Desferoxamine (DFO)-mediated iron chelation: rationale for a novel approach to therapy for brain cancer. J. Neurooncol. 67 (2004) 367-377
12. Erikson K.M., Pinero D.J., Connor J.R., and Beard J.L. Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J. Nutr. 127 (1997) 2030-2038
13. Erikson K.M., Jones B.C., and Beard J.L. Iron deficiency alters dopamine transporter functioning in rat striatum. J. Nutr. 130 (2000) 2831-2837
14. Erikson K.M., Jones B.C., Hess E.J., Zhang Q., and Beard J.L. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol. Biochem. Behav. 69 (2001) 409-418
15. Gainetdinov R.R., and Caron M.G. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 261-284
16. Grantham-McGregor S., and Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J. Nutr. 131 (2001) 649S-666S (discussion)
17. Holton K.L., Loder M.K., and Melikian H.E. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat. Neurosci. 8 (2005) 881-888
18. Hsieh M.M., Lupas G., Rychlik J., Dziennis S., Habecker B.A., and Lewis E.J. ERK1/2 is a negative regulator of homeodomain protein Arix/Phox2a. J. Neurochem. 94 (2005) 1719-1727
19. Hunt J.R., Zito C.A., Erjavec J., and Johnson L.K. Severe or marginal iron deficiency affects spontaneous physical activity in rats. Am. J. Clin. Nutr. 59 (1994) 413-418
20. Jayanthi L.D., Samuvel D.J., and Ramamoorthy S. Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization. J. Biol. Chem. 279 (2004) 19315-19326
21. Kim C.H., Hwang D.Y., Park J.J., and Kim K.S. A proximal promoter domain containing a homeodomain-binding core motif interacts with multiple transcription factors, including HoxA5 and Phox2 proteins, and critically regulates cell type-specific transcription of the human norepinephrine transporter gene. J. Neurosci. 22 (2002) 2579-2589
22. Kippenberger A.G., Palmer D.J., Comer A.M., Lipski J., Burton L.D., and Christie D.L. Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: evidence for its association with secretory granules in PC12 cells. J. Neurochem. 73 (1999) 1024-1032
23. Kwik-Uribe C.L., Golub M.S., and Keen C.L. Chronic marginal iron intakes during early development in mice alter brain iron concentrations and behavior despite postnatal iron supplementation. J. Nutr. 130 (2000) 2040-2048
24. Larkin E., and Rao G.A. Importance of fetal and neonatal iron: adequacy for normal development of central nervous system. In: Dobbing J. (Ed). Brain, Behavior and Iron in the Infant Diet (1990), Springer-Verlag, London, UK 43-63
25. Little K.Y., Elmer L.W., Zhong H., Scheys J.O., and Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol. Pharmacol. 61 (2002) 436-445
26. Loder M.K., and Melikian H.E. The dopamine transporter constitutively internalizes and recycles in a protein kinase C-regulated manner in stably transfected PC12 cell lines. J. Biol. Chem. 278 (2003) 22168-22174
27. Lozoff B. Perinatal iron deficiency and the developing brain. Pediatr. Res. 48 (2000) 137-139
28. Lozoff B., Klein N.K., Nelson E.C., McClish D.K., Manuel M., and Chacon M.E. Behavior of infants with iron-deficiency anemia. Child Dev. 69 (1998) 24-36
29. Lozoff, B.B.J., Connor, J.R., Felt, B., Georgieff, M.K., Schallert, T., in press. Long-lasting neural and behavioral effects of early iron deficiency in infancy. Nutr. Rev.
30. Melikian H.E. Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol. Ther. 104 (2004) 17-27
31. Melikian H.E., McDonald J.K., Gu H., Rudnick G., Moore K.R., and Blakely R.D. Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody. J. Biol. Chem. 269 (1994) 12290-12297
32. Miranda M., Wu C.C., Sorkina T., Korstjens D., and Sorkin A. Enhanced ubiquitylation and accelerated degradation of the dopamine transporter mediated by protein kinase C. J. Biol. Chem. 280 (2005) 35617-35624
33. Nelson C., Erikson K., Pinero D.J., and Beard J.L. In vivo dopamine metabolism is altered in iron-deficient anemic rats. J. Nutr. 127 (1997) 2282-2288
34. Ortiz E., Pasquini J.M., Thompson K., Felt B., Butkus G., Beard J., and Connor J.R. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J. Neurosci. Res. 77 (2004) 681-689
35. Peirano P., Algarin C., Garrido M., Pizarro F., Roncagliolo M., and Lozoff B. Interaction of iron deficiency anemia and neurofunctions in cognitive development. Nestle Nutr. Workshop Ser. Clin. Perform. Progr. (2001) 19-35 (discussion 35-19)
36. Petrat F., Rauen U., and de Groot H. Determination of the chelatable iron pool of isolated rat hepatocytes by digital fluorescence microscopy using the fluorescent probe, phen green SK. Hepatology 29 (1999) 1171-1179
37. Pinero D.J., Li N.Q., Connor J.R., and Beard J.L. Variations in dietary iron alter brain iron metabolism in developing rats. J. Nutr. 130 (2000) 254-263
38. Pollitt E. Developmental sequel from early nutritional deficiencies: conclusive and probability judgements. J. Nutr. 130 (2000) 350S-353S
39. Rao R., de Ungria M., Sullivan D., Wu P., Wobken J., Nelson C., and Georgieff M. Perinatal brain iron deficiency increases the vulnerability of rat hippocampus to hypoxic ischemic insult. J. Nutr. 129 (1999) 199-206
40. Reeves P.G., Nielsen F.H., and Fahey Jr. G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123 (1993) 1939-1951
41. Roncagliolo M., Garrido M., Walter T., Peirano P., and Lozoff B. Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: delayed maturation of auditory brainstem responses. Am. J. Clin. Nutr. 68 (1998) 683-690
42. Sacchetti P., Brownschidle L.A., Granneman J.G., and Bannon M.J. Characterization of the 5′-flanking region of the human dopamine transporter gene. Brain Res. Mol. Brain Res. 74 (1999) 167-174
43. Sung U., Apparsundaram S., Galli A., Kahlig K.M., Savchenko V., Schroeter S., Quick M.W., and Blakely R.D. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J. Neurosci. 23 (2003) 1697-1709
44. Theil E.C., and Eisenstein R.S. Combinatorial mRNA regulation: iron regulatory proteins and iso-iron-responsive elements (Iso-IREs). J. Biol. Chem. 275 (2000) 40659-40662
45. Torres G.E., Yao W.D., Mohn A.R., Quan H., Kim K.M., Levey A.I., Staudinger J., and Caron M.G. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30 (2001) 121-134
46. Walter T., Pino P., Pizarro F., and Lozoff B. Prevention of iron-deficiency anemia: comparison of high- and low-iron formulas in term healthy infants after six months of life. J. Pediatr. 132 (1998) 635-640
47. Weinberg J., Dallman P.R., and Levine S. Iron deficiency during early development in the rat: behavioral and physiological consequences. Pharmacol. Biochem. Behav. 12 (1980) 493-502
48. Yehuda S., and Youdim M.B. Brain iron: a lesson from animal models. Am. J. Clin. Nutr. 50 (1989) 618-625
49. Youdim M.B., Green A.R., Bloomfield M.R., Mitchell B.D., Heal D.J., and Grahame-Smith D.G. The effects of iron deficiency on brain biogenic monoamine biochemistry and function in rats. Neuropharmacology 19 (1980) 259-267
50. Youdim M.B., Ben-Shachar D., Ashkenazi R., and Yehuda S. Brain iron and dopamine receptor function. Adv. Biochem. Psychopharmacol. 37 (1983) 309-321
51. Youdim M.B., Sills M.A., Heydorn W.E., Creed G.J., and Jacobowitz D.M. Iron deficiency alters discrete proteins in rat caudate nucleus and nucleus accumbens. J. Neurochem. 47 (1986) 794-799
52. Youdim M.B., Ben-Shachar D., Yehuda S., and Riederer P. The role of iron in the basal ganglion. Adv. Neurol. 53 (1990) 155-162